Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Transcranial Magnetic Stimulation × Clear all

Phase

Phase NA 11 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cisplatin 1290 Carboplatin 1206 Cyclophosphamide 1152 Gemcitabine 1051 Bevacizumab 1042 Paclitaxel 1030 Radiotherapy 1019 Docetaxel 950 pembrolizumab 882 Oxaliplatin 795 Capecitabine 779 Fluorouracil 730 Rituximab 634 Doxorubicin 573 Nivolumab 571 Dexamethasone 571 Etoposide 563 Irinotecan 545 Leucovorin 506 Pemetrexed 431 Drug Therapy 412 Cetuximab 405 Cytarabine 404 Trastuzumab 401 Filgrastim 381 Magnetic Resonance Spectroscopy 377 Prednisone 364 Lenalidomide 348 Bortezomib 345 Temozolomide 337

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02283944 2021-09-20

TMS Electrochemotherapy for Glioblastoma Multiforme

University of Aarhus

Phase 2 Withdrawn

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡